It is now approved by the United States Food and Drug Administration (FDA) to treat type 2 diabetes and chronic weight management, as multiple randomized clinical trials have shown that liraglutide is safe and effective in reducing blood glucose levels, promoting weight loss, and lowering cardiovascular risk [2]
Oral and topical forms of GSH have shown moderate success in reducing melanin levels with minimal side effects, while intravenous use, though popular, raises significant safety concerns, including risks of anaphylaxis and liver damage
GLP-1 (GLP-1 receptor agonist, GLP-1 RA)
Since natural GLP-1 is rapidly deactivated by an enzyme in our blood, by the time GLP-1 is secreted by our gut, makes it through our liver, heart, and lungs, then out into our arteries, only to later reach the veins where the lab tech is pulling out blood, the levels we see are lower than the arterial levels that GLP-1 receptors are exposed to throughout our body, though only by a relatively small amount